These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22452606)

  • 1. Treatment of Guillain-Barré syndrome: a review.
    Rajabally YA
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):330-4. PubMed ID: 22452606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel Therapeutic Interventions in Guillain-Barré Syndrome: Review and Future Perspective].
    Misawa S
    Brain Nerve; 2015 Nov; 67(11):1421-8. PubMed ID: 26560957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome.
    Charra B; Hachimi A; Benslama A; Motaouakkil S
    Pan Afr Med J; 2014; 18():35. PubMed ID: 25368724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin and Guillain-Barré syndrome.
    Harel M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
    Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
    J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVIG treatment and prognosis in Guillain-Barré syndrome.
    van Doorn PA; Kuitwaard K; Walgaard C; van Koningsveld R; Ruts L; Jacobs BC
    J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S74-8. PubMed ID: 20396937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.
    El-Bayoumi MA; El-Refaey AM; Abdelkader AM; El-Assmy MM; Alwakeel AA; El-Tahan HM
    Crit Care; 2011 Jul; 15(4):R164. PubMed ID: 21745374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome: immunopathogenesis and therapeutic targets.
    Liu S; Zhang WW; Jia L; Zhang HL
    Expert Opin Ther Targets; 2024 Mar; 28(3):131-143. PubMed ID: 38470316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial.
    Haridy NA; Shehab MM; Khedr EM
    Restor Neurol Neurosci; 2023; 41(5-6):203-217. PubMed ID: 38217554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Hughes RA; Wijdicks EF; Barohn R; Benson E; Cornblath DR; Hahn AF; Meythaler JM; Miller RG; Sladky JT; Stevens JC;
    Neurology; 2003 Sep; 61(6):736-40. PubMed ID: 14504313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Guillain-Barré Syndrome].
    Nomura K
    Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action.
    Shahrizaila N; Yuki N
    Expert Opin Pharmacother; 2011 Jul; 12(10):1551-60. PubMed ID: 21473704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of dys-immune neuropathies.
    Nobile-Orazio E
    J Neurol; 2005 Apr; 252(4):385-95. PubMed ID: 15834625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between IVIg and plasma exchange in Guillain-Barré syndrome: a review and decision analysis of the two treatment modalities.
    Dawson WB; Phillips LH
    Clin Neuropharmacol; 1995 Oct; 18(5):377-90. PubMed ID: 8665552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.